Published in Vision Res on June 18, 2008
Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model. Proc Natl Acad Sci U S A (2011) 1.01
Vector platforms for gene therapy of inherited retinopathies. Prog Retin Eye Res (2014) 0.94
Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients. Hum Gene Ther (2012) 0.90
Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives. Viruses (2010) 0.87
Gene therapy of inherited retinal degenerations: prospects and challenges. Hum Gene Ther (2015) 0.87
A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo. J Gene Med (2010) 0.86
Gene replacement therapy for retinal CNG channelopathies. Mol Genet Genomics (2013) 0.82
Gene Therapy of ABCA4-Associated Diseases. Cold Spring Harb Perspect Med (2015) 0.81
Retinal transduction profiles by high-capacity viral vectors. Gene Ther (2014) 0.80
Sustained gene expression in the retina by improved episomal vectors. Tissue Eng Part A (2014) 0.79
Subretinal gene delivery using helper-dependent adenoviral vectors. Cell Biosci (2011) 0.76
Lentiviral vectors as tools to understand central nervous system biology in mammalian model organisms. Front Mol Neurosci (2015) 0.76
Helper-Dependent Adenoviral Vectors. J Genet Syndr Gene Ther (2011) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
Retinitis pigmentosa. Lancet (2006) 13.62
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature (2007) 13.56
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med (2006) 13.51
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science (2000) 10.40
Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A (1987) 7.91
Gene therapy restores vision in a canine model of childhood blindness. Nat Genet (2001) 7.88
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1990) 7.06
Gene therapy -- promises, problems and prospects. Nature (1997) 6.02
Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med (1997) 4.87
Cell fate determination in the vertebrate retina. Proc Natl Acad Sci U S A (1996) 4.81
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci U S A (1996) 4.76
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med (1999) 4.61
Gene therapy death prompts review of adenovirus vector. Science (1999) 4.33
A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci U S A (1996) 3.89
AAV vector integration sites in mouse hepatocellular carcinoma. Science (2007) 3.73
Murine leukemia induced by retroviral gene marking. Science (2002) 3.59
Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U S A (1997) 3.40
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med (1999) 3.39
Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron (1992) 3.25
Translocation of RNA-coated gold particles through the nuclear pores of oocytes. J Cell Biol (1988) 3.08
Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet (2000) 3.00
Improved system for helper-dependent adenoviral vector production. Mol Ther (2003) 2.71
Effective gene therapy with nonintegrating lentiviral vectors. Nat Med (2006) 2.70
Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome. J Virol (1990) 2.62
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther (2006) 2.59
Gene therapy clinical trials worldwide to 2007--an update. J Gene Med (2007) 2.56
Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci U S A (1999) 2.41
Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther (2004) 2.21
Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A (2001) 2.20
A retinitis pigmentosa GTPase regulator (RPGR)-deficient mouse model for X-linked retinitis pigmentosa (RP3). Proc Natl Acad Sci U S A (2000) 2.19
Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog. Invest Ophthalmol Vis Sci (2003) 2.18
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol (2005) 2.16
Photoreceptor cell rescue in retinal degeneration (rd) mice by in vivo gene therapy. Nat Med (1996) 2.12
Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J Virol (2005) 2.09
Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J Virol (2007) 2.05
The relationship between opsin overexpression and photoreceptor degeneration. Invest Ophthalmol Vis Sci (2001) 1.98
In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther (2001) 1.93
Update on adenovirus and its vectors. J Gen Virol (2000) 1.93
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
Tissue-specific and developmental regulation of rod opsin chimeric genes in transgenic mice. Neuron (1991) 1.88
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther (2001) 1.81
An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A (1998) 1.76
Characterization of adeno-associated virus genomes isolated from human tissues. J Virol (2005) 1.72
Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One (2006) 1.71
Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum Mol Genet (1996) 1.67
Gene therapy progress and prospects: the eye. Gene Ther (2006) 1.66
Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J Virol (1999) 1.64
Rhodopsin signaling and organization in heterozygote rhodopsin knockout mice. J Biol Chem (2004) 1.64
A hybrid photoreceptor expressing both rod and cone genes in a mouse model of enhanced S-cone syndrome. PLoS Genet (2005) 1.61
Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther (2005) 1.61
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther (2006) 1.59
Nanoparticles of compacted DNA transfect postmitotic cells. J Biol Chem (2003) 1.58
Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum Mol Genet (1996) 1.56
Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy. Gene Ther (2005) 1.48
Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP. Invest Ophthalmol Vis Sci (2005) 1.47
Gene replacement therapy in the retinal degeneration slow (rds) mouse: the effect on retinal degeneration following partial transduction of the retina. Hum Mol Genet (2001) 1.46
Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol (2005) 1.46
Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum Gene Ther (1997) 1.45
Versatility of AAV vectors for retinal gene transfer. Vision Res (2007) 1.44
AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter. Invest Ophthalmol Vis Sci (2007) 1.44
A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet (1994) 1.41
Rhodopsin-iCre transgenic mouse line for Cre-mediated rod-specific gene targeting. Genesis (2005) 1.40
Rescue of photoreceptor function by AAV-mediated gene transfer in a mouse model of inherited retinal degeneration. Gene Ther (1997) 1.39
Mouse models of ocular diseases. Vis Neurosci (2005) 1.37
One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications. Mol Ther (2007) 1.36
Encapsidated adenovirus mini-chromosome-mediated delivery of genes to the retina: application to the rescue of photoreceptor degeneration. Hum Mol Genet (1998) 1.32
Gene therapy. Seeking the cause of induced leukemias in X-SCID trial. Science (2003) 1.28
Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. Gene Ther (2004) 1.28
Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol Ther (2006) 1.24
phiC31 integrase confers genomic integration and long-term transgene expression in rat retina. Invest Ophthalmol Vis Sci (2005) 1.24
Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea. Mol Ther (2007) 1.22
Immune response following intraocular delivery of recombinant viral vectors. Gene Ther (2003) 1.20
AAV-mediated gene transfer for retinal diseases. Expert Opin Biol Ther (2006) 1.15
Efficient gene transfer into retinal cells using adenoviral vectors: dependence on receptor expression. Invest Ophthalmol Vis Sci (2004) 1.12
Efficiency of lentiviral transduction during development in normal and rd mice. Mol Vis (2006) 1.09
Signal-mediated nuclear transport in proliferating and growth-arrested BALB/c 3T3 cells. J Cell Biol (1991) 1.06
Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol Vis (2005) 1.06
Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models. Invest Ophthalmol Vis Sci (2006) 1.04
Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery. Invest Ophthalmol Vis Sci (1997) 1.04
Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates. Arch Ophthalmol (2005) 1.02
Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors. J Gene Med (2006) 0.99
Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector. Invest Ophthalmol Vis Sci (2002) 0.98
A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassette. J Virol (2006) 0.97
Does recombinant adeno-associated virus-vectored proximal region of mouse rhodopsin promoter support only rod-type specific expression in vivo? Mol Vis (2006) 0.97
AAV vectors and tumorigenicity. Nat Biotechnol (2007) 0.95
Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer. Mol Vis (2003) 0.95
Neurobiology: right timing for retina repair. Nature (2006) 0.95
Retinal cell type expression specificity of HIV-1-derived gene transfer vectors upon subretinal injection in the adult rat: influence of pseudotyping and promoter. J Gene Med (2005) 0.94
Adenoviral-mediated gene transfer to retinal explants during development and degeneration. Exp Eye Res (2004) 0.93
A burst of differentiation in the outer posterior retina of the eleven-week human fetus: an ultrastructural study. Vis Neurosci (1990) 0.92
Immune responses limit adenovirally mediated gene expression in the adult mouse eye. Gene Ther (1998) 0.92
Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors--implications for gene therapy. Mol Ther (2002) 0.92
Immune responses to gene product of inducible promoters. Curr Gene Ther (2007) 0.92
Integration of adenovirus type 2 DNA at a limited number of cellular sites in productively infected cells. J Virol (1981) 0.91
Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases. Curr Gene Ther (2005) 0.90
Evidence of protein transduction but not intercellular transport by proteins fused to HIV tat in retinal cell culture and in vivo. Mol Ther (2003) 0.90
Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy. J Gene Med (2007) 0.90
Improved retinal transduction in vivo and photoreceptor-specific transgene expression using adenovirus vectors with modified penton base. Mol Ther (2007) 0.89